DAVIS A BRIAN 4
4 · Verrica Pharmaceuticals Inc. · Filed Oct 21, 2019
Insider Transaction Report
Form 4
DAVIS A BRIAN
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2019-10-18+125,000→ 125,000 totalExercise: $14.65Exp: 2029-10-18→ Common Stock (125,000 underlying)
Footnotes (1)
- [F1]25% of the total shares subject to the option shall vest on October 18, 2020 and 1/48th of the total shares subject to the option shall vest monthly thereafter over the remaining three years of the vesting period, subject to the Reporting Person's continuous service through such vesting date.